FDA Panel Reconsiders Roche’s Breast Cancer Drug
FDA panel to vote on rescinding approval for use of Roche’s Avastin to treat breast cancer Breast cancer – Food and Drug Administration – Bevacizumab – Health – Cancer

Read more on ABC News